Protein Structure/Function by Quantum Chemistry and NMR
通过量子化学和 NMR 分析蛋白质结构/功能
基本信息
- 批准号:6834588
- 负责人:
- 金额:$ 27.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-01-01 至 2006-12-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
EXCEED THE SPACE PROVIDED. The broad, long term objectives of this research are to use NMR and quantum chemical methods to learn more about protein structure and function and to apply these methods to protein structure prediction and refinement, including the topic of enzyme/inhibitor or drug/target interactions. The first specific aim is to compute NMR shielding surfaces for side-chains in amino acids; to calibrate these theoretical results versus experimental shielding tensors and orientations and to incorporate these results into a Web Chemical Shift calculator as well as the CNS program, for use in protein and peptide structure determination. Second, we will use combined multinuclear (1H, 2H, 170) NMR and quantum chemical methods to investigate hydrogen bonding and electrostatics in peptides and proteins. Third, we will use NMR, x-ray diffraction and quantum chemical methods to probe enzyme-inhibitor interactions, focussing on the bisphosphonate class of drugs which inhibit the enzymes farnesyl pyrophosphate and geranylgeranyl pyrophosphate synthase and which have potent bone anti-resorptive, anti-cancer and anti-parasitic activity. The fourth and final specific aim is to use NMR and quantum chemical methods to develop improved approaches for quantitative structure-activity relationship studies (quantum QSAR applications). PERFORMANCE SITE ========================================Section End===========================================
超出所提供的空间。本研究的长远目标是利用核磁共振和量子化学方法更多地了解蛋白质的结构和功能,并将这些方法应用于蛋白质结构的预测和改进,包括酶/抑制剂或药物/靶标相互作用的主题。第一个具体目标是计算氨基酸侧链的核磁共振屏蔽面;将这些理论结果与实验屏蔽张量和方向进行校准,并将这些结果合并到Web化学移位计算器和CNS程序中,用于蛋白质和肽结构的测定。其次,我们将使用组合的多核(1H, 2H, 170) NMR和量子化学方法来研究多肽和蛋白质中的氢键和静电。第三,我们将使用核磁共振、x射线衍射和量子化学方法来探测酶-抑制剂的相互作用,重点研究抑制法尼基焦磷酸和香叶基焦磷酸合成酶的双膦酸类药物,这些药物具有强效的骨抗吸收、抗癌和抗寄生虫活性。第四个也是最后一个具体目标是使用核磁共振和量子化学方法来开发改进的定量构效关系研究方法(量子QSAR应用)。网站性能 ======================================== 节结束 ===========================================
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric Oldfield其他文献
Eric Oldfield的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric Oldfield', 18)}}的其他基金
Next generation bisphosphonates for chemo- and immuno-therapy
用于化疗和免疫治疗的下一代双膦酸盐
- 批准号:
8444316 - 财政年份:2011
- 资助金额:
$ 27.88万 - 项目类别:
Next generation bisphosphonates for chemo- and immuno-therapy
用于化疗和免疫治疗的下一代双膦酸盐
- 批准号:
8627146 - 财政年份:2011
- 资助金额:
$ 27.88万 - 项目类别:
Next generation bisphosphonates for chemo- and immuno-therapy
用于化疗和免疫治疗的下一代双膦酸盐
- 批准号:
8825340 - 财政年份:2011
- 资助金额:
$ 27.88万 - 项目类别:
Next generation bisphosphonates for chemo- and immuno-therapy
用于化疗和免疫治疗的下一代双膦酸盐
- 批准号:
8085202 - 财政年份:2011
- 资助金额:
$ 27.88万 - 项目类别:
Prenyl Synthase Inhibitors: Novel Anti-Infective Agents
异戊二烯合酶抑制剂:新型抗感染剂
- 批准号:
7984564 - 财政年份:2002
- 资助金额:
$ 27.88万 - 项目类别:
Prenyldiphosphate Synthase Inhibitors: Novel Anti-Infective Agents
异戊二烯二磷酸合酶抑制剂:新型抗感染剂
- 批准号:
7686803 - 财政年份:2002
- 资助金额:
$ 27.88万 - 项目类别:
Prenyl Synthase Inhibitors: Novel Anti-Infective Agents
异戊二烯合酶抑制剂:新型抗感染剂
- 批准号:
8532682 - 财政年份:2002
- 资助金额:
$ 27.88万 - 项目类别:
相似海外基金
Development of on-chip membrane protein preparation method and structure/function analysis of giant membrane proteins
片上膜蛋白制备方法开发及巨膜蛋白结构/功能分析
- 批准号:
23K04926 - 财政年份:2023
- 资助金额:
$ 27.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deep transformers for integrating protein sequence, structure and interaction data to predict function
用于整合蛋白质序列、结构和相互作用数据以预测功能的深度转换器
- 批准号:
2308699 - 财政年份:2023
- 资助金额:
$ 27.88万 - 项目类别:
Continuing Grant
How to build a protein factory? Linking structure and function of the plant endoplasmic reticulum
如何建造蛋白质工厂?
- 批准号:
BB/X006417/1 - 财政年份:2023
- 资助金额:
$ 27.88万 - 项目类别:
Research Grant
Integrative deep learning algorithms for understanding protein sequence-structure-function relationships: representation, prediction, and discovery
用于理解蛋白质序列-结构-功能关系的集成深度学习算法:表示、预测和发现
- 批准号:
10712082 - 财政年份:2023
- 资助金额:
$ 27.88万 - 项目类别:
IIBR Research Methods: Probing the structure, abundance, dynamics, and function of protein complexes within their cellular environment
IIBR 研究方法:探测细胞环境中蛋白质复合物的结构、丰度、动态和功能
- 批准号:
2327468 - 财政年份:2023
- 资助金额:
$ 27.88万 - 项目类别:
Continuing Grant
Understanding how membrane composition directs membrane protein structure and function
了解膜成分如何指导膜蛋白结构和功能
- 批准号:
10630518 - 财政年份:2023
- 资助金额:
$ 27.88万 - 项目类别:
The in cell structure and function of an intrinsically disordered plant stress protein
本质无序植物应激蛋白的细胞内结构和功能
- 批准号:
RGPIN-2016-04253 - 财政年份:2022
- 资助金额:
$ 27.88万 - 项目类别:
Discovery Grants Program - Individual
Oat protein as a sustainable protein source: Structure-function characterization and utilization in novel applications
燕麦蛋白作为可持续的蛋白质来源:结构功能表征和新应用中的利用
- 批准号:
DGECR-2022-00304 - 财政年份:2022
- 资助金额:
$ 27.88万 - 项目类别:
Discovery Launch Supplement
Identification and analysis of the structure-function relationship of eukaryotic glycolipids involved in protein sorting and insertion into membanes
参与蛋白质分选和插入膜的真核糖脂的结构-功能关系的鉴定和分析
- 批准号:
22K19262 - 财政年份:2022
- 资助金额:
$ 27.88万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Structure-function investigations of protein partnerships governing neuronal signaling
控制神经信号传导的蛋白质伙伴关系的结构功能研究
- 批准号:
RGPIN-2018-05838 - 财政年份:2022
- 资助金额:
$ 27.88万 - 项目类别:
Discovery Grants Program - Individual